The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Advancement Program, 2018Testing the Ability of Clenbuterol to Prevent or Modify the Course of Parkinson's Disease
Study Rationale:
Protein alpha-synuclein clumps in the brains of people with Parkinson's disease (PD), forming Lewy bodies. Recent studies have suggested that beta-2 adrenoreceptor agonists -- drugs... -
Mitochondrial Biomarkers Program, 2018Changes in Mitochondrial DNA as Diagnostic and Progression Biomarkers of Parkinson's Disease
Study Rationale:
Biomarkers, or objective measures, of Parkinson's disease (PD) could help identify individuals at risk of PD and predict disease progression. According to recent studies, changes in... -
Inflammation Biomarkers Program, 2018The Kynurenine Pathway as a New Therapeutic Target and Source of Biomarkers for Parkinson's Disease
Study Rationale:
Inflammation is involved in the death of brain cells in Parkinson's disease (PD), but the exact relationship between the two is unclear. We propose that inflammation damages the brain... -
Inflammation Biomarkers Program, 2018Can Brain Inflammation Predict Dementia Associated with Parkinson's Disease?
Study Rationale:
For the reasons not well understood, people with Parkinson's disease are at risk for developing dementia, a decline in memory, thinking and/or language abilities severe enough to... -
LRRK2 Biology Consortium, 2017The Role of Variations in the LRRK2 Gene in Parkinson's Disease
Study Rationale:
Genes can influence one's chance of developing Parkinson's disease (PD), but it's not entirely clear how. In this study, we will use cells from people with Parkinson's to test how the... -
Mitochondrial Biomarkers Program, 2018Studying the Production of Mitochondria to Find New Therapeutic Targets for Parkinson's Disease
Study Rationale:
It is known that the brain cells damaged in Parkinson's disease (PD) struggle to generate energy. This is because mitochondria -- powerhouses of the cell -- are faulty in these cells...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.